Cerebral Vasospasm
📧 Sign up to get email alerts when something new happens for Cerebral Vasospasm.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2018-03-22Clinical Trial Update: Cervical Spinal Cord Stimulation in Cerebral Vasospasm [NA]
A clinical trial investigating cervical spinal cord stimulation for cerebral vasospasm has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2017-04-17Clinical Trial Update: Effect of Red Blood Cell Transfusion on Brain Metabolism in Patients With Subarachnoid Hemorrhage [Phase 1, Phase 2]
A Phase 1/2 clinical trial assessed whether red blood cell transfusion affects brain metabolism in patients with subarachnoid hemorrhage and…
-
CLINICAL_TRIALS trial_result · 2017-02-15Clinical Trial Update: Balloon Prophylaxis of Aneurysmal Vasospasm [Phase 2]
Phase 2 clinical trial update assessing balloon angioplasty to prophylactically prevent cerebral vasospasm associated with intracranial aneu…
-
CLINICAL_TRIALS trial_result · 2017-02-13Clinical Trial Update: Bilateral Bispectral Index (BIS) Study
The Bilateral Bispectral Index (BIS) study completed enrollment/status update for patients with subarachnoid hemorrhage who developed cerebr…
-
CLINICAL_TRIALS withdrawal · 2016-12-22Clinical Trial Update: An Innovative Non-invasive Acoustic Approach to Detect and Monitor Cerebral Vasospasm
A clinical trial evaluating a non-invasive acoustic method to detect and monitor cerebral vasospasm after subarachnoid hemorrhage has been w…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-11-28Clinical Trial Update: Remote Ischemic Preconditioning in Subarachnoid Hemorrhage [Phase 1]
This clinical trial update notes the completion of a Phase 1 study investigating remote ischemic preconditioning for patients with subarachn…
-
CLINICAL_TRIALS trial_result · 2016-05-17Clinical Trial Update: Stellate Ganglion Block Using Ultrasound Guidance For Treatment Of Post Clipping Cerebral Vasospasm [Phase 1]
This Phase 1 trial evaluated ultrasound-guided stellate ganglion block for treating cerebral vasospasm after aneurysm clipping; the study ha…
-
CLINICAL_TRIALS trial_result · 2016-02-11Clinical Trial Update: Safety and Feasibility of Hypertonic Saline Solution After Aneurysmal Subarachnoid Hemorrhage: [Phase 1, Phase 2]
This clinical trial update discusses the safety and feasibility of using hypertonic saline solution in patients after aneurysmal subarachnoi…
-
CLINICAL_TRIALS trial_result · 2016-01-01Clinical Trial Update: Continuous Neurophysiological Monitoring Detection of Cerebral Vasospasm in Aneurysmal Subarachnoid Hemorrhage Subjects [EARLY_Phase 1]
An early phase 1 trial evaluating continuous neurophysiological monitoring to detect cerebral vasospasm in patients with aneurysmal subarach…
-
CLINICAL_TRIALS trial_result · 2015-11-25Clinical Trial Update: Use of Simvastatin for the Prevention of Vasospasm in Aneurysmal Subarachnoid Hemorrhage [NA]
Clinical trial update indicating termination of a study evaluating simvastatin to prevent vasospasm after aneurysmal subarachnoid hemorrhage…
-
CLINICAL_TRIALS withdrawal · 2015-11-11Clinical Trial Update: Effect of Intraventricular tPA Following Aneurysmal Subarachnoid Hemorrhage [Phase 1, Phase 2]
The clinical trial investigating intraventricular tPA after aneurysmal subarachnoid hemorrhage (Phase 1/2) has been withdrawn.
-
CLINICAL_TRIALS research · 2015-10-02Clinical Trial Update: Use of Brain Oxygen Tension Level and Cleaved-tau Protein to Detect Vasospasm After SAH
A terminated clinical trial explored brain oxygen tension and cleaved-tau protein as potential biomarkers to detect cerebral vasospasm after…
-
CLINICAL_TRIALS withdrawal · 2015-09-24Clinical Trial Update: Carbonic Anhydrase Antagonism in Subarachnoid Hemorrhage [Phase 2]
A Phase 2 trial investigating a carbonic anhydrase antagonist for subarachnoid hemorrhage was withdrawn.
-
FDA approval · 2015-08-26FDA Approved: NYMALIZE — Supplemental Application (Azurity Pharmaceuticals, Inc.)
FDA approved a supplemental application for NYMALIZE (nimodipine) by Azurity Pharmaceuticals, Inc.
-
CLINICAL_TRIALS withdrawal · 2015-03-25Clinical Trial Update: Sildenafil for Prevention of Cerebral Vasospasm [Phase 2]
A Phase 2 trial investigating sildenafil to prevent cerebral vasospasm after subarachnoid hemorrhage was withdrawn. The study was conducted …
-
CLINICAL_TRIALS trial_result · 2015-03-05Clinical Trial Update: Safety Study of Dantrolene in Subarachnoid Hemorrhage [Phase 1, Phase 2]
A Phase 1/Phase 2 safety study of dantrolene in patients with subarachnoid hemorrhage was completed, with results posted in 2015.
-
CLINICAL_TRIALS research · 2015-02-05Clinical Trial Update: Safety Study of Carotid Body Neurostimulation to Treat Cerebral Vasospasm [NA]
A safety study of carotid body neurostimulation for treating cerebral vasospasm after aneurysmal subarachnoid hemorrhage is being tracked, b…
-
CLINICAL_TRIALS research · 2014-12-09Clinical Trial Update: Computed Tomographic (CT) Perfusion and CT Angiography as Screening Tools for Vasospasm Following Subarachnoid Hemorrhage
This entry reports a completed clinical trial evaluating computed tomography perfusion and CT angiography as screening tools for detecting v…
-
CLINICAL_TRIALS trial_result · 2014-11-20Clinical Trial Update: Role of Proteomics and Metallomics in Cerebral Vasospasm Following Subarachnoid Hemorrhage
A completed clinical trial evaluating the role of proteomics and metallomics in cerebral vasospasm following subarachnoid hemorrhage.
-
CLINICAL_TRIALS trial_result · 2014-09-03Clinical Trial Update: Quality of Life in Elderly After Aneurysmal Subarachnoid Hemorrhage (SAH)
This completed clinical trial evaluated quality of life outcomes in elderly patients after aneurysmal subarachnoid hemorrhage. Related condi…
-
CLINICAL_TRIALS trial_result · 2014-08-29Clinical Trial Update: Safety Study of Nicardipine to Treat Cerebral Vasospasm [Phase 2]
Terminated Phase 2 safety study evaluating nicardipine for treating cerebral vasospasm; results have been posted.
-
FDA approval · 2013-06-21FDA Approved: NIMODIPINE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
The FDA approved a supplemental application for nimodipine from Heritage Pharmaceuticals (Avet), marking approval of an additional generic p…
-
CLINICAL_TRIALS research · 2012-12-20Clinical Trial Update: A Registry Study of Shuxuening Injection Used in Hospitals in China
A registry study in China evaluating Shuxuening Injection for cardiovascular and cerebrovascular conditions, with the current status not dis…
-
CLINICAL_TRIALS trial_result · 2012-05-25Clinical Trial Update: Safety Study of Dantrolene to Treat Cerebral Vasospasm After Subarachnoid Hemorrhage [Phase 1, Phase 2]
Phase 1/2 safety study of dantrolene for treating cerebral vasospasm after subarachnoid hemorrhage has completed with results posted in 2012…
-
FDA approval · 2009-11-17FDA Approved: NICARDIPINE HYDROCHLORIDE — Original Application (Civica, Inc.)
FDA approved Civica, Inc.'s nicardipine hydrochloride as an original generic application (ANDA 090534), making a generic version of this cal…